...
首页> 外文期刊>European journal of anaesthesiology >Assessment of ondansetron and droperidol for the prevention of post-operative nausea and vomiting after cholecystectomy and minor gynaecological surgery performed by laparoscopy.
【24h】

Assessment of ondansetron and droperidol for the prevention of post-operative nausea and vomiting after cholecystectomy and minor gynaecological surgery performed by laparoscopy.

机译:评估恩丹西酮和氟哌利多在腹腔镜下进行胆囊切除术和小型妇科手术后预防恶心和呕吐的发生率。

获取原文
获取原文并翻译 | 示例
           

摘要

The anti-emetic effects of ondansetron and droperidol were evaluated in 134 ASA Grade I and II female patients, scheduled for laparoscopic cholecystectomy and minor gynaecological laparoscopic surgery, who were randomly assigned to receive ondansetron 4 mg or droperidol 75 micrograms kg-1 intravenously immediately after induction of anaesthesia. The patients were assessed 1, 6, 12 and 24 h after surgery for intensity of nausea and number of vomiting episodes. In the case of the patients undergoing laparoscopy, vomiting episodes occurred in a similar proportion in patients treated with ondansetron or droperidol, with the probability of the Type I error of 0.05 and the Type error II of 0.1. Although there was no difference between the two groups in emetic episodes following all laparoscopic procedures and gynaecological laparoscopic surgery, there was a significant difference between these parameters after laparoscopic cholecystectomy. The patients treated with ondansetron experienced a lower intensity of nausea (P = 0.04) after laparoscopic cholecystectomy, less frequent severe nausea (P = 0.02) and episodes of vomiting (P = 0.04) when compared with those in the droperidol group. We conclude, that despite the result the droperidol prophylaxis appears to be an effective alternative to ondansetron in all patients undergoing laparoscopy, the ondansetron prophylaxis is superior to droperidol in patients undergoing laparoscopic cholecystectomy.
机译:在计划进行腹腔镜胆囊切除术和小妇科腹腔镜手术的134例ASA ASA I和II级女性患者中评估了恩丹西酮和氟哌利多的止吐作用,他们随机分配给恩丹西酮4毫克或氟哌利多75毫克kg-1静脉注射麻醉诱导。在手术后1、6、12和24小时评估患者的恶心强度和呕吐发作次数。对于接受腹腔镜检查的患者,在使用恩丹西酮或氟哌利多治疗的患者中呕吐的发生率相似,I型错误的可能性为0.05,II型错误的可能性为0.1。尽管两组在所有腹腔镜手术和妇科腹腔镜手术后的呕吐发作之间没有差异,但是在腹腔镜胆囊切除术后这些参数之间存在显着差异。与氟哌利多组相比,使用恩丹西酮治疗的患者在腹腔镜胆囊切除术后恶心程度较低(P = 0.04),严重恶心的发生率较低(P = 0.02),并且呕吐发作的发生率(P = 0.04)。我们得出结论,尽管在所有接受腹腔镜检查的患者中,氟哌利多的预防作用似乎是替代恩丹西酮的有效替代方法,但在接受腹腔镜胆囊切除术的患者中,恩丹西酮的预防作用优于氟哌利多。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号